慢性肺心病合并急性心肌梗死误诊原因分析及对策探讨

来源 :中国医疗前沿 | 被引量 : 0次 | 上传用户:liongliong557
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的总结分析慢性肺源性心脏病(CPHD)合并急性心肌梗死(AMI)的临床特点及误诊原因,探讨早期诊断、治疗策略,以降低误诊率和死亡率。方法对误诊的26例CPHD合并AMI患者的临床资料结合文献进行回顾性分析。结果 49例CPHD合并AMI患者中,死亡15例,死亡率30.61%,误诊26例,误诊率53.06%。结论 CPHD合并AMI患者因临床表现不典型,并发症严重,多因认为原发病加重、忽视检查而误诊,误诊率和死亡率均较高。早期诊断、及时有效治疗是降低CPHD合并AMI患者死亡率的关键,对肺心病住院患者常规检测并定期复查18导联心电图、心肌酶、肌钙蛋白有助于及时诊断AMI。 Objective To summarize the clinical features and causes of misdiagnosis of chronic pulmonary heart disease (CPHD) complicated with acute myocardial infarction (AMI) and to explore the early diagnosis and treatment strategies to reduce the misdiagnosis rate and mortality rate. Methods The clinical data of 26 patients with misdiagnosed CPHD and AMI were retrospectively analyzed. Results Among the 49 patients with CPHD complicated with AMI, 15 died, with a mortality rate of 30.61% and 26 patients misdiagnosed with a rate of 53.06%. Conclusions The patients with CPHD complicated with AMI have atypical clinical manifestations and severe complications. Many patients are considered misdiagnosed as misdiagnosis and misdiagnosis and mortality as the primary disease aggravated. Early diagnosis and timely and effective treatment are the key to reduce the mortality of patients with CPHD complicated with AMI. To routinely check in hospitalized patients with pulmonary heart disease and regularly review the 18-lead ECG, myocardial enzymes and troponin are helpful to timely diagnose AMI.
其他文献
通过水热法成功地合成了C+xHSO4-插层化合物,在前人工作的基础上设计了石墨硫酸插层化合物的结构模型.较好地解释了C+xHSO4-插层化合物中各原子的排布方式,并通过X射线(00L)